GPCRStructure Therapeutics Inc.

$40.33

$18.5752 weeks$93.79

Price

$40.33+102%1Y

1M-23%1Y+102%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

5/10

Value52

Quality44

Momentum54

Growth-

Strongest Momentum, weakest Quality · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a clinical stage global biopharmaceutical company developing novel oral small molecule therapeutics to treat a wide range of chronic diseases with unmet medical need. Our differentiated technology platform leverages both structure-based drug discovery and our expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (“GPCRs”). These important receptors regulate numerous and diverse physiological and pathological processes.

In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$3.43B

1Y Return+102%

5Y Return-